Monte Rosa Therapeutics, Inc. (GLUE) Stock Total Returns
Growth of $10,000 chart
2021-06-24 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$8,263
Total Return
-17.37%
CAGR
-3.89%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.34% |
| Median | -2.49% |
| Best | +116.22% |
| Worst | -60.88% |
| % of Windows Positive | 46.2% |
1-Year (252 Trading Days)
| Average | +6.98% |
| Median | -21.59% |
| Best | +345.92% |
| Worst | -80.67% |
| % of Windows Positive | 36.2% |
3-Year (756 Trading Days)
| Average | -7.01% |
| Median | -50.23% |
| Best | +252.79% |
| Worst | -88.23% |
| % of Windows Positive | 29.1% |
Risk Metrics
| Maximum Drawdown | -94.08% |
| Average Drawdown | -75.13% |
| Drawdown Duration | 1155 Trading Days (Unrecovered) |
| Sortino Ratio | 0.73 |
| Calmar Ratio | -0.04 |
| CVaR (5%) | -11.73% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +11.61% (+47.06% ann.) | +$1160.71 | $0.00 | $0.00 | $0.00 |
| 2025 | +125.94% | +$12593.63 | $0.00 | $0.00 | $0.00 |
| 2024 | +22.83% | +$2283.20 | $0.00 | $0.00 | $0.00 |
| 2023 | -25.76% | $2575.56 | $0.00 | $0.00 | $0.00 |
| 2022 | -62.73% | $6273.26 | $0.00 | $0.00 | $0.00 |
| 2021 partial | -3.59% (-6.78% ann.) | $358.83 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Reopening reflation / fiscal boom / supply bottlenecks partial | June 24, 2021 – November 29, 2021 | -9.11% | -19.82% | $911.24 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -60.80% | -63.01% | $6080.45 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -26.00% | -14.99% | $2600.00 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +194.12% | +98.91% | +$19411.80 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.